linperlisib plus chidamide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for linperlisib plus chidamide, covering 2023-09-14 to 2023-09-14. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study [Phase 1, Phase 2]